Atlas Trials

Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection

Clinical trial NCT05767528 · UNKNOWN

Trial details

NCT number
NCT05767528
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Muscle-Invasive Bladder Carcinoma
Start date
2022-12-08
Primary completion
2023-12-08
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.